Skip to content
TrialScanner

NCT02288234

Telavancin Observational Use Registry (TOUR)

No phase registeredCompletedCPIXLead

Registry record

Lead sponsor
Cumberland Pharmaceuticals
Conditions
Hospital Acquired Bacterial Pneumonia; Complicated Skin and Skin Structure Infections; Ventilator Associated Bacterial Pneumonia; Gram Positive Infection
Primary completion
Jun 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02288234 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02288234: Telavancin Observational Use... | TrialScanner